Safety and tolerability issues were also similar across groups, suggesting that dose adjustment is not required in patients with hepatic impairment
Clinical data suggest it may also improve blood glucose levels, HbA1c, insulin sensitivity, blood pressure, and lipid-related markers , making it a broader metabolic therapy candidate rather than a weight-loss-only drug
According to health policy research from KFF, approximately 1 in 8 U.S
Most prescriptions are written for four weeks, with renewals based on progress and tolerance Results often require ongoing support
Cost: $449 per month (plus $40 telehealth consult) If not approved, $65 will be retained for virtual consult and lab fees
Patients on GnRH agonist therapy (Lupron, Orilissa) who add tirzepatide gain 60% less weight and maintain better insulin sensitivity compared to hormonal therapy alone